High THC cannabis products are under intense scrutiny, and with good reason. Kevin Sabet, CEO of SAM Smart Approaches to Marijuana, joins us to dissect the cannabis industry's parallels with big tobacco, especially concerning unproven health claims and the relentless drive for profit. We examine a noteworthy New York Times article and question whether New York's $1 billion in cannabis sales is worth the potential cost to public health. Our discussion focuses on prioritizing health over profit, learning from the tobacco industry's past mistakes, and the crucial role of effective regulation in safeguarding public health.

Our global audience is at the heart of what we do, and your support is invaluable. We are grateful to Kevin for his insights and extend our appreciation to listeners across dozens of countries and countless cities. We're excited to continue bringing you the most pressing news and updates, and we encourage you to share our podcast with others who care about the future of drug policy and public health. If our conversations resonate with you, please leave us a five-star review and share your thoughts as we strive to spark change and meaningful dialogue.

Follow the work of SAM and FDPS below:

https://learnaboutsam.org/
https://gooddrugpolicy.org/
https://thedrugreport.org/

On X:
https://twitter.com/learnaboutsam
https://twitter.com/GoodDrugPolicy
https://twitter.com/KevinSabet
https://twitter.com/LukeNiforatos

On Facebook: https://www.facebook.com/learnaboutsam